Co-stimulation of the fc receptor and interleukin-12 receptor on human natural killer cells leads to increased expression of cd25

por Duggan, Megan C., Campbell, Amanda R., McMichael, Elizabeth L., Opheim, Kallan S., Levine, Kala M., Bhave, Neela, Culbertson, Michelle C., Noel, Tiffany, Yu, Lianbo, Carson, WE
Publicado en Oncoimmunology (2017)

MiR-21 Enhances Melanoma Invasiveness via Inhibition of Tissue Inhibitor of Metalloproteinases 3 Expression: In Vivo Effects of MiR-21 Inhibitor

por Martin del Campo, Sara E., Latchana, Nicholas, Levine, Kala M., Grignol, Valerie P., Fairchild, Ene T., Jaime-Ramirez, Alena Cristina, Dao, Thao-Vi, Karpa, Volodymyr I., Carson, Mary, Ganju, Akaansha, Chan, Anthony N., Carson III, William E.
Publicado en PLoS One (2015)

A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma

por Suarez-Kelly, Lorena P., Levine, Kala M., Olencki, Thomas E., del Campo, Sara E. Martin, Streacker, Elizabeth A., Brooks, Taylor R., Karpa, Volodymyr I., Markowitz, Joseph, Bingman, Anissa K., Geyer, Susan M., Kendra, Kari L., Carson, William E.
Publicado en Cancer Immunol Immunother (2019)

Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancer

por Wesolowski, Robert, Duggan, Megan C., Stiff, Andrew, Markowitz, Joseph, Trikha, Prashant, Levine, Kala M., Schoenfield, Lynn, Abdel-Rasoul, Mahmoud, Layman, Rachel, Ramaswamy, Bhuvaneswari, Macrae, Erin R., Lustberg, Maryam B., Reinbolt, Raquel E., Mrozek, Ewa, Byrd, John C., Caligiuri, Michael A., Mace, Thomas A., Carson, William E.
Publicado en Cancer Immunol Immunother (2017)

MicroRNA profiling of patient plasma for clinical trials using bioinformatics and biostatistical approaches

por Markowitz, Joseph, Abrams, Zachary, Jacob, Naduparambil K, Zhang, Xiaoli, Hassani, John N, Latchana, Nicholas, Wei, Lai, Regan, Kelly E, Brooks, Taylor R, Uppati, Sarvani R, Levine, Kala M, Bekaii-Saab, Tanios, Kendra, Kari L, Lesinski, Gregory B, Howard, J Harrison, Olencki, Thomas, Payne, Philip R, Carson, William E
Publicado en Onco Targets Ther (2016)

A phase I/II trial of cetuximab in combination with interleukin-12 administered to patients with unresectable primary or recurrent head and neck squamous cell carcinoma

por McMichael, Elizabeth L., Benner, Brooke, Atwal, Lakhvir S., Courtney, Nicholas B., Mo, Xiaokui, Davis, Melanie E., Campbell, Amanda R., Duggan, Megan C., Williams, Kallan, Martin, Kyle, Levine, Kala M., Olaverria Salavaggione, Gonzalo N., Noel, Tiffany, Ganju, Akansha, Uppati, Sarvani, Paul, Bonnie, Olencki, Thomas, Teknos, Theodoros N., Savvides, Panos, Tridandapani, Susheela, Byrd, John C., Caligiuri, Michael A., Liu, Stephen V., Carson, William E.
Publicado en Clin Cancer Res (2019)

The Raf Kinase Inhibitor Sorafenib Inhibits JAK-STAT Signal Transduction in Human Immune Cells

por del Campo, Sara E. Martin, Levine, Kala M., Mundy-Bosse, Bethany L., Grignol, Valerie P., Fairchild, Ene T., Campbell, Amanda R., Trikha, Prashant, Mace, Thomas A., Paul, Bonnie K., Jaime-Ramirez, Alena Cristina, Markowitz, Joseph, Kondadasula, Sri Vidya, Guenterberg, Kristan D., McClory, Susan, Karpa, Volodymyr I., Pan, Xueliang, Olencki, Thomas E., Monk, J. Paul, Mortazavi, Amir, Tridandapani, Susheela, Lesinski, Gregory B., Byrd, John C., Caligiuri, Michael A., Shah, Manisha H., Carson, William E.
Publicado en J Immunol (2015)